Hypocholesterolaemic treatment in coronary unit: from statins to anti PCSK9 therapies and bempedoic acid

The knowledge that roughly 20% of survivors from an acute coronary syndrome (ACS) event experience a subsequent ischaemic cardiovascular event within 24 months with a 5-year mortality range between 19 and 22% highlights the importance of the lipid-lowering strategies in the secondary prevention afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferri, Nicola, Corsini, Alberto, Ruscica, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
CCC 2023 - State of the Art Cardiology Supplement Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120985/
https://www.ncbi.nlm.nih.gov/pubmed/37091668
http://dx.doi.org/10.1093/eurheartjsupp/suad068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120985/
https://www.ncbi.nlm.nih.gov/pubmed/37091668
http://dx.doi.org/10.1093/eurheartjsupp/suad068

Ejemplares similares